304 related articles for article (PubMed ID: 38169585)
1. Engineered bacterial outer membrane vesicles: a versatile bacteria-based weapon against gastrointestinal tumors.
Zheng K; Feng Y; Li L; Kong F; Gao J; Kong X
Theranostics; 2024; 14(2):761-787. PubMed ID: 38169585
[TBL] [Abstract][Full Text] [Related]
2. Engineered Bacterial Outer Membrane Vesicles with Lipidated Heterologous Antigen as an Adjuvant-Free Vaccine Platform for Streptococcus suis.
Li Q; Zhou G; Fei X; Tian Y; Wang S; Shi H
Appl Environ Microbiol; 2023 Mar; 89(3):e0204722. PubMed ID: 36809058
[TBL] [Abstract][Full Text] [Related]
3. Outer membrane vesicles (OMVs) enabled bio-applications: A critical review.
Huang Y; Nieh MP; Chen W; Lei Y
Biotechnol Bioeng; 2022 Jan; 119(1):34-47. PubMed ID: 34698385
[TBL] [Abstract][Full Text] [Related]
4. Bacterial outer membrane vesicles as a candidate tumor vaccine platform.
Wang S; Guo J; Bai Y; Sun C; Wu Y; Liu Z; Liu X; Wang Y; Wang Z; Zhang Y; Hao H
Front Immunol; 2022; 13():987419. PubMed ID: 36159867
[TBL] [Abstract][Full Text] [Related]
5. Bacterial outer membrane vesicles as potential biological nanomaterials for antibacterial therapy.
Huang W; Meng L; Chen Y; Dong Z; Peng Q
Acta Biomater; 2022 Mar; 140():102-115. PubMed ID: 34896632
[TBL] [Abstract][Full Text] [Related]
6. Bacterial outer membrane vesicles as a platform for biomedical applications: An update.
Li M; Zhou H; Yang C; Wu Y; Zhou X; Liu H; Wang Y
J Control Release; 2020 Jul; 323():253-268. PubMed ID: 32333919
[TBL] [Abstract][Full Text] [Related]
7. Outer membrane vesicles engineered to express membrane-bound antigen program dendritic cells for cross-presentation to CD8
Schetters STT; Jong WSP; Horrevorts SK; Kruijssen LJW; Engels S; Stolk D; Daleke-Schermerhorn MH; Garcia-Vallejo J; Houben D; Unger WWJ; den Haan JMM; Luirink J; van Kooyk Y
Acta Biomater; 2019 Jun; 91():248-257. PubMed ID: 31003032
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in various bio-applications of bacteria-derived outer membrane vesicles.
Sadeghi L; Mohit E; Moallemi S; Ahmadi FM; Bolhassani A
Microb Pathog; 2023 Dec; 185():106440. PubMed ID: 37931826
[TBL] [Abstract][Full Text] [Related]
9. Outer Membrane Vesicle Vaccine Platforms.
Micoli F; Adamo R; Nakakana U
BioDrugs; 2024 Jan; 38(1):47-59. PubMed ID: 37796436
[TBL] [Abstract][Full Text] [Related]
10. Bacterial outer membrane vesicles engineered with lipidated antigens as a platform for
Irene C; Fantappiè L; Caproni E; Zerbini F; Anesi A; Tomasi M; Zanella I; Stupia S; Prete S; Valensin S; König E; Frattini L; Gagliardi A; Isaac SJ; Grandi A; Guella G; Grandi G
Proc Natl Acad Sci U S A; 2019 Oct; 116(43):21780-21788. PubMed ID: 31591215
[TBL] [Abstract][Full Text] [Related]
11. Outer membrane vesicles as a platform for the discovery of antibodies to bacterial pathogens.
Lei EK; Azmat A; Henry KA; Hussack G
Appl Microbiol Biotechnol; 2024 Feb; 108(1):232. PubMed ID: 38396192
[TBL] [Abstract][Full Text] [Related]
12. Bacterial Outer Membrane Vesicles: From Discovery to Applications.
Sartorio MG; Pardue EJ; Feldman MF; Haurat MF
Annu Rev Microbiol; 2021 Oct; 75():609-630. PubMed ID: 34351789
[TBL] [Abstract][Full Text] [Related]
13. Bacterial outer membrane vesicles in cancer: Biogenesis, pathogenesis, and clinical application.
Li D; Zhu L; Wang Y; Zhou X; Li Y
Biomed Pharmacother; 2023 Sep; 165():115120. PubMed ID: 37442066
[TBL] [Abstract][Full Text] [Related]
14. Bacterial outer membrane vesicle-based cancer nanovaccines.
Gao X; Feng Q; Wang J; Zhao X
Cancer Biol Med; 2022 Sep; 19(9):1290-300. PubMed ID: 36172794
[TBL] [Abstract][Full Text] [Related]
15. Bioengineering bacterial outer membrane vesicles as vaccine platform.
Gerritzen MJH; Martens DE; Wijffels RH; van der Pol L; Stork M
Biotechnol Adv; 2017 Sep; 35(5):565-574. PubMed ID: 28522212
[TBL] [Abstract][Full Text] [Related]
16. Outer membrane vesicles as platform vaccine technology.
van der Pol L; Stork M; van der Ley P
Biotechnol J; 2015 Sep; 10(11):1689-706. PubMed ID: 26912077
[TBL] [Abstract][Full Text] [Related]
17. Bacterial Outer Membrane Vesicles as a Versatile Tool in Vaccine Research and the Fight against Antimicrobial Resistance.
Zhu Z; Antenucci F; Villumsen KR; Bojesen AM
mBio; 2021 Aug; 12(4):e0170721. PubMed ID: 34372691
[TBL] [Abstract][Full Text] [Related]
18. Surface Mineralization of Engineered Bacterial Outer Membrane Vesicles to Enhance Tumor Photothermal/Immunotherapy.
Chen X; Li P; Luo B; Song C; Wu M; Yao Y; Wang D; Li X; Hu B; He S; Zhao Y; Wang C; Yang X; Hu J
ACS Nano; 2024 Jan; 18(2):1357-1370. PubMed ID: 38164903
[TBL] [Abstract][Full Text] [Related]
19. A modular vaccine platform enabled by decoration of bacterial outer membrane vesicles with biotinylated antigens.
Weyant KB; Oloyede A; Pal S; Liao J; Jesus MR; Jaroentomeechai T; Moeller TD; Hoang-Phou S; Gilmore SF; Singh R; Pan DC; Putnam D; Locher C; de la Maza LM; Coleman MA; DeLisa MP
Nat Commun; 2023 Jan; 14(1):464. PubMed ID: 36709333
[TBL] [Abstract][Full Text] [Related]
20. The role and mechanisms of gram-negative bacterial outer membrane vesicles in inflammatory diseases.
Chen S; Lei Q; Zou X; Ma D
Front Immunol; 2023; 14():1157813. PubMed ID: 37398647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
